Post-approval studies (Phase 4)Active Not RecruitingNCT06864026
What this trial is testing
Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Who this might be right for
Psoriatic ArthritisOverweight or Obesity
Eli Lilly and Company 200